Literature DB >> 16172165

Increased cross-bridge cycling rate in stunned myocardium.

Wei Dong Gao1, Tieying Dai, Daniel Nyhan.   

Abstract

Decreased Ca2+ responsiveness of the myofilaments underlies myocardial stunning. Given that cross-bridge cycling is a major determinant of myofilament behavior, we quantified cross-bridge cycling rate in stunned myocardium. After stabilization, rat hearts were subjected to 20 min of no-flow global ischemia and 30 min of reperfusion at 37 degrees C. Control hearts were perfused continuously at 37 degrees C for 60 min. Trabeculae were dissected and chemically skinned with 1% Triton X-100. The muscles were then activated with solutions of varied Ca2+ concentration ([Ca2+]). Force-[Ca2+] relations, rate of force redevelopment after release (k(tr)), muscle stiffness (k(m)), and myofilament ATP consumption were determined. Maximal Ca2+-activated force (Fmax) was depressed in stunned myocardium (49 +/- 5 vs. 82 +/- 5 mN/mm2, P < 0.01). Western immunoblotting showed degradation of troponin I in stunned myocardium. The k(tr) at Fmax was significantly increased in stunned muscles (19.82 +/- 2.74 vs. 13.19 +/- 0.96 s(-1), 22 degrees C, P < 0.01; 7.49 +/- 0.52 vs. 5.81 +/- 0.54 s(-1), 10 degrees C, P < 0.05). The ratio of k(m) measured at 100 Hz over that at 1 Hz, during Fmax, is lower in stunned muscles (8.22 +/- 1.56 vs. 12.94 +/- 0.71, P < 0.05). In comparison with k(m) at rigor, k(m) at Fmax is significantly lower in the stunned group (78.82 +/- 6.11 vs. 93.27 +/- 3.03%, P < 0.05). Myofilament ATP consumption at Fmax did not change in stunned muscles (5,901 +/- 952 vs. 5,596 +/- 972 pmol x microl(-1) x min(-1), P = 0.49). These results show that cross-bridge cycling is increased in stunned myocardium. Such increases are likely the result of increased transition rate from force-generating states to non-force-generating states. Thus stunned myocardium still maintains ATP consumption in spite of lower force development, rationalizing the long-standing paradox of decreased force but unchanged oxygen consumption in the postischemic heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172165     DOI: 10.1152/ajpheart.00493.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Functional significance of C-terminal mobile domain of cardiac troponin I.

Authors:  Nazanin Bohlooli Ghashghaee; Bertrand C W Tanner; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2017-09-27       Impact factor: 4.013

2.  Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zone.

Authors:  Rafael Shimkunas; Om Makwana; Kimberly Spaulding; Mona Bazargan; Michael Khazalpour; Kiyoaki Takaba; Mehrdad Soleimani; Bat-Erdene Myagmar; David H Lovett; Paul C Simpson; Mark B Ratcliffe; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

3.  Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle.

Authors:  Kittipong Tachampa; Tomoyoshi Kobayashi; Helen Wang; Anne F Martin; Brandon J Biesiadecki; R John Solaro; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

4.  Doppler strain imaging closely reflects myocardial energetic status in acute progressive ischemia and indicates energetic recovery after reperfusion.

Authors:  Josef Korinek; Partho P Sengupta; Jianwen Wang; Abel Romero-Corral; Anna E Boukatina; Jan Vitek; Vijay K Krishnamoorthy; Stephen S Cha; Petras P Dzeja; Andre Terzic; Bijoy K Khandheria; Marek Belohlavek
Journal:  J Am Soc Echocardiogr       Date:  2008-03-06       Impact factor: 5.251

5.  The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments.

Authors:  Agnieszka Galińska; Victoria Hatch; Roger Craig; Anne M Murphy; Jennifer E Van Eyk; C-L Albert Wang; William Lehman; D Brian Foster
Journal:  Circ Res       Date:  2009-12-24       Impact factor: 17.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.